| 1 |
35380342 | CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: a cross-talk between FGF21 and the NRF2 pathway. | 2022 Apr 1 |
2 |
| 2 |
35592903 | Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis. | 2022 May 19 |
1 |
| 3 |
33770521 | Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation. | 2021 May |
2 |
| 4 |
34159680 | The BAFF/NFκB axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts. | 2021 Sep |
1 |
| 5 |
34473785 | Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells. | 2021 |
6 |
| 6 |
34482117 | Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis. | 2021 Oct |
2 |
| 7 |
34530350 | SIRT6 silencing overcomes resistance to sorafenib by promoting ferroptosis in gastric cancer. | 2021 Nov 5 |
2 |
| 8 |
34768109 | ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma. | 2021 Dec |
1 |
| 9 |
31367013 | SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC. | 2020 Mar |
1 |
| 10 |
32304346 | An Artemisinin-Derivative-(NHC)Gold(I) Hybrid with Enhanced Cytotoxicity through Inhibition of NRF2 Transcriptional Activity. | 2020 Jul 13 |
1 |
| 11 |
32388267 | Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer. | 2020 Jul |
2 |
| 12 |
32560747 | Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells. | 2020 Dec 10 |
4 |
| 13 |
30647407 | Activation of c-Met in cancer cells mediates growth-promoting signals against oxidative stress through Nrf2-HO-1. | 2019 Jan 15 |
2 |
| 14 |
29061583 | Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells. | 2018 Jan |
2 |
| 15 |
26403645 | Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. | 2016 Jan |
3 |
| 16 |
27015352 | Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. | 2016 Aug |
1 |
| 17 |
27184800 | Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib. | 2016 May 16 |
1 |
| 18 |
23314856 | The noncytotoxic dose of sorafenib sensitizes Bel-7402/5-FU cells to 5-FU by down-regulating 5-FU-induced Nrf2 expression. | 2013 Jun |
4 |
| 19 |
20428777 | Sorafenib with doxorubicin augments cytotoxicity to renal cell cancer through PERK inhibition. | 2010 Jun |
3 |